Literature DB >> 20514059

Deal watch: CureDM licenses regenerative diabetes therapy to Sanofi-Aventis.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20514059     DOI： 10.1038/nrd3197

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  2 in total

1.  Type 1 diabetes.

Authors:  Paul Burn
Journal:  Nat Rev Drug Discov       Date:  2010-03       Impact factor: 84.694

2.  Discovery of a human peptide sequence signaling islet neogenesis.

Authors:  Claresa S Levetan; Loraine V Upham; Shaoping Deng; Lisa Laury-Kleintop; Vladimir Kery; Roger Nolan; Jack Quinlan; Claudio Torres; Rita J El-Hajj
Journal:  Endocr Pract       Date:  2008-12       Impact factor: 3.443
  2 in total
  1 in total

1.  Deal watch: Harnessing creative risk sharing.

Authors:  Tibor Papp
Journal:  Nat Rev Drug Discov       Date:  2010-09       Impact factor: 84.694
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.